Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001169232-05-002135
Filing Date
2005-04-15
Accepted
2005-04-15 17:26:47
Documents
5
Period of Report
2004-03-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM 10-Q d63368_10q.txt 10-Q/A 29586
2 CERTIFICATION PURSUANT TO SECTION 302 d63368_ex31-1.txt EX-31.1 3635
3 CERTIFICATION PURSUANT TO SECTION 302 d63368_ex31-2.txt EX-31.2 3629
4 CERTIFICATION PURSUANT TO SECTION 906 d63368_ex32-1.txt EX-32.1 1448
5 CERTIFICATION PURSUANT TO SECTION 906 d63368_ex32-2.txt EX-32.2 1539
  Complete submission text file 0001169232-05-002135.txt   41372
Mailing Address 350 5TH AVENUE SUITE 7120 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7120 NEW YORK NY 10118 2122440555
DAXOR CORP (Filer) CIK: 0000027367 (see all company filings)

EIN.: 132682108 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-09999 | Film No.: 05754748
SIC: 3841 Surgical & Medical Instruments & Apparatus